Vincristine, Mannitol

Vincristine is an anti-cancer medication that belongs to a group of drugs called vinca alkaloids. Mannitol, on the other hand, is a type of sugar that is often used as an osmotic diuretic, helping to increase urine production. Together, Vincristine and Mannitol form a combination medication, often used in the treatment of specific types of cancer and to manage fluid levels in the body.
The primary purpose of Vincristine is to stop the growth of cancer cells by interfering with the cell division process. This medication is commonly used to treat cancers such as leukemia, lymphoma, and brain tumors. Vincristine may only be administered by a healthcare professional due to its potency and potential side effects.
Mannitol, in combination with Vincristine, is often used to manage fluid balance in patients. As an osmotic diuretic, Mannitol promotes increased urine production by pulling water into the kidneys, thereby helping to reduce fluid build-up. This can be particularly useful for patients experiencing conditions such as cerebral edema, a swelling of the brain due to excess fluid, or other instances where fluid management is necessary.